SCHEDULE 13D

Company

Corvus Pharmaceuticals, Inc.

Filed

April 1, 2016

Accession Number

0000947871-16-001083

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →